Sartorius Stedim Biotech S.A.
SDMHF
$193.02
-$26.41-12.04%
OTC PK
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 55.06M | 77.74M | 48.61M | 28.03M | |
| Total Depreciation and Amortization | 36.79M | 88.41M | 40.93M | 83.77M | |
| Total Amortization of Deferred Charges | 60.88M | -- | 44.98M | -- | |
| Total Other Non-Cash Items | 65.07M | 40.18M | 21.53M | 72.78M | |
| Change in Net Operating Assets | 69.15M | -64.58M | 147.64M | 99.60M | |
| Cash from Operations | 286.95M | 141.75M | 303.69M | 284.19M | |
| Capital Expenditure | -136.32M | -86.14M | -85.28M | -77.40M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -1.13M | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -1.98M | -- | -213.20K | -- | |
| Cash from Investing | -138.29M | -87.28M | -85.49M | -77.40M | |
| Total Debt Issued | 400.00K | 12.90M | 3.70M | 0.00 | |
| Total Debt Repaid | 0.00 | 0.00 | -9.10M | -29.80M | |
| Issuance of Common Stock | 4.20M | 1.10M | 2.80M | 3.10M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | 0.00 | -76.15M | 0.00 | 0.00 | |
| Other Financing Activities | -3.70M | -200.00K | -8.80M | -133.10M | |
| Cash from Financing | 1.05M | -60.49M | -12.15M | -175.68M | |
| Foreign Exchange rate Adjustments | -1.40M | -3.40M | 3.30M | 219.90K | |
| Miscellaneous Cash Flow Adjustments | -- | -113.50K | -- | -- | |
| Net Change in Cash | 148.31M | -9.53M | 209.36M | 31.33M | |